JPMorgan Downgrades Insulet Corporation (PODD) to Neutral
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $152.01 +2.69%
Rating Summary:
22 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Rating Summary:
22 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Join SI Premium – FREE
JPMorgan downgraded Insulet Corporation (NASDAQ: PODD) from Overweight to Neutral with a price target of $35.00 (from $45.00).
For an analyst ratings summary and ratings history on Insulet Corporation click here. For more ratings news on Insulet Corporation click here.
Shares of Insulet Corporation closed at $38.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY): Bloom Energy Corporation (NYSE: BE); GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO); and Insulet Corporation (NASD
- Viking Holdings (VIK) PT Raised to $121 at UBS Ahead of Q2 Earnings
- Palo Alto Networks (PANW) PT Raised to $390 at UBS, Neutral Rating Maintained
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
